.png){kind=logo}
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jun 21, 2024With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleepMedtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that...
Jun 4, 2024Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technologyMedtronic, a global leader in healthcare technology, today announced that Dr. Goran Petrovski M.D., Ph.D. has joined the company’s Diabetes Operating Unit as Medical Affairs Director. Dr....
- Jun 3, 2024
Medtronic, a global leader in medical technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) 84th Scientific Sessions. Following the one-year...
- Apr 30, 2024Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy.
Medtronic, a global leader in healthcare technology, today announced the results of the randomized controlled Closed- loop insulin delivery in pregnant women with type 1 diabetes: a randomized...
- Apr 23, 2024Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems.
Medtronic, a global leader in healthcare technology, shared results from separate studies highlighting that the Medtronic MiniMed™ 780G system is a cost-effective therapy option for people...
- Feb 22, 2024Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*
Medtronic plc, the global leader in medical technology, announced the unveiling of new data on its MiniMed™ 780G system at the upcoming 17th International Conference on Advanced Technologies and...
Jan 31, 2024Actress, writer and producer Alexandra Park, best known for her role on The Royals and Australian series Home and Away, is partnering with Medtronic Diabetes to help others living with type 1...
Jan 8, 2024With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable,...
- Nov 8, 2023New guidelines will expand access to automated insulin delivery technology among wider population.
Medtronic plc, the leading global healthcare technology company, applauds the guidance* published by the National Institute for Health and Care Excellence (NICE) in the United Kingdom recommending...
Oct 5, 2023Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.Medtronic plc (NYSE:MDT), a global leader in medical technology, presented multi-continent real-world data demonstrating that use of the MiniMed™ 780G system allows people living with diabetes...
- Sep 25, 2023The company will initiate a phased launch of its disposable SimpleraTM CGM at the meeting, its smallest and most comfortable CGM to-date that’s integrated with the InPenTM smart insulin pen
DUBLIN – September 25, 2023 – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its participation in the upcoming European Association for the Study of...
- Jul 6, 2023Orders will be processed immediately and shipments will start in the coming weeks
DUBLIN – July 6, 2023 – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today that its MiniMed™ 780G system with the new Guardian™ 4 sensor requiring no...
- Jun 23, 2023
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets,...
Jun 23, 2023Results show that the use of InPen resulted in an increase in Time in Range among those in the studiesDUBLIN – June 23, 2023 – Medtronic plc (NYSE:MDT), the global leader in medical technology, presented an oral presentation and a late-breaking poster on its InPen™ Smart Insulin Pen (SIP)....
- May 25, 2023Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. (KOSDAQ: 294090), manufacturer of...
- May 2, 2023
Today, Medtronic Canada announced that it has received a licence from Health Canada for the Guardian™ 4 sensor to be used in conjunction with the MiniMed™ 780G insulin pump system† for the...
- Apr 25, 2023Resolution follows the recent FDA approval of the MiniMed™ 780G system featuring the world's first and only automated insulin delivery system with real-time meal detection technology*
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) lifted the warning letter received at the company's Diabetes...
- Apr 21, 2023Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its MiniMed™ 780G system with the Guardian™ 4 sensor...
- Feb 24, 2023A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced one-year data from the ADAPT study (n=82), the first multi-national randomized controlled study comparing the...
- Feb 16, 2023
Medtronic plc, the global leader in medical technology, today announced its participation in the upcoming 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)...
Dec 9, 2022Medtronic Canada is pleased to announce Health Canada has licensed the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days with Medtronic insulin...
- Nov 15, 2022Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day...
Nov 1, 2022The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in rangeMedtronic Canada is pleased to announce that it has received a license from Health Canada for its MiniMed™ 780G system for people living with type 1 diabetes. This system with advanced hybrid...
Oct 18, 2022Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in RangeMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology. The ADAPT study is...